Prolonged inhibition of nitric oxide synthesis in severe septic shock: A clinical study

Critical Care Medicine

Volumn 26, Issue 4, 1998, Pages 660-667

  Avontuur, Jurgen A M ^a   Tutein Nolthenius, Rudolf P ^a   Van Bodegom, Jan W ^a   Bruining, Hajo A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Analogs of; Catecholamines; Hypotension; Inhibitors of; Intensive care; L NAME; L arginine; Mortality; Nitric oxide; Nitric oxide synthesis; Septic shock

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESUSCITATION; SEPTIC SHOCK;

ADULT; AGED; APACHE; CRITICAL CARE; ENZYME INHIBITORS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; MALE; MIDDLE AGED; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROSPECTIVE STUDIES; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 0031892252     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199804000-00012     Document Type: Article

References (37)

1. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328:953-963
2. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142
3. Palmer RM, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333:664-666
4. Avontuur JA, Bruining HA, Ince C: Nitric oxide causes dysfunction of coronary autoregulation in endotoxemic rats. Cardiovasc Res 1997; 35:368-376
5. Rees DD, Palmer RM, Schulz R, et al: Characterisation of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101:746-752
6. G-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol 1990; 101: 625-639
7. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci U S A 1990; 87:3629-3632
8. Meyer J, Traber LD, Nelson S, et al: Reversal of hyperdynamic responses to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 1992; 73:324-328
9. Lorente JA, Landin L, De Pablo R, et al: L-arginine pathway in the sepsis syndrome. Crit Care Med 1993; 21:1287-1295
10. Petros A, Lamb G, Leone A, et al: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28:34-39
11. Preiser JC, Lejeune P, Roman A, et al: Methylene blue administration in septic shock: A clinical trial. Crit Care Med 1995; 23:259-264
12. Nava E, Palmer RM, Moncada S: Inhibition of nitric oxide synthesis in septic shock: How much is beneficial? Lancet 1991; 338:1555-1557
13. Hata JS, Dellinger RP: Nitric oxide inhibition in the treatment of septic shock. Crit Care Med 1995; 23:1621-1624
14. Bone RC, Fischer CJ, Clemmer TP, et al: The sepsis syndrome: A valid clinical entity. Crit Care Med 1989; 17:389-393
15. G-nitro-arginine methyl ester in the anesthetized rabbit: Venous vasomotion and plasma levels. J Vasc Res 1992; 29:290-292
16. Knaus WA, Le Gall JR, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
17. Elebute EA, Stoner HB: The grading of sepsis. Br J Surg 1983; 70:29-31
18. Griffiths MJ, Messent M, Mac Allister RJ, et al: Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 1993; 110:963-968
19. Dinarello CA, Gelfand JA, Wolff SM: Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993; 269:1829-1835
20. Stuehr DJ, Marietta MA: Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A 1985; 82:7738-7742
21. Vallance P, Patton S, Bhagat K, et al: Direct measurement of nitric oxide in human beings. Lancet 1995; 345: 153-154
22. G-nitro-L-arginine methylester in canine blood in vitro. Arch Pharmacol 1993; 347:342-345
23. Brady JB, Poole-Wilson PA, Harding SE, et al: Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992; 263:H1963-H1966
24. Avontuur JA, Bruining HA, Ince C: Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 1995; 76: 418-425
25. G-methyl-L-arginine inhibits endotoxin-induced nitrite/ nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 1990; 48:565-569
26. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48-57
27. Teale DM, Akinson AM: Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis and that is not cured by antibiotics alone. J Antimicrob Chemother 1992; 30:839-842
28. Szabo C, Mitchell JA, Thiemermann C, et al: Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 1993; 108:786-792
29. Liu SF, Adcock IM, Old RW, et al: Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med 1996; 24:1219-1225
30. Gutierrez G, Palizas F, Doglio G, et al: Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992; 339:195-199
31. Radomski MW, Palmer RM, Moncada S: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; ii:1057-1058
32. May GR, Crook P, Moore PK, et al: The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. Br J Pharmacol 1991; 102:759-763
33. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl acad Sci U S A 1991; 88:4651-1655
34. Rossaint R, Falke KJ, Slama K, et al: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405
35. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al: Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338:1173-1174
36. Sprague RS, Thiemermann C, Vane JR: Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits. Proc Natl Acad Sci USA 1992; 89:8711-8715
37. G-nitro-L-arginine infusion in porcine endotoxin shock. Crit Care Med 1995; 23:909-918